Litcius/Paper detail

Efficacy of antivirals and bivalent mRNA vaccines against SARS-CoV-2 isolate CH.1.1

Ryuta Uraki, Mutsumi Ito, Maki Kiso, Seiya Yamayoshi, Kiyoko Iwatsuki‐Horimoto, Yuko Sakai‐Tagawa, Yuri Furusawa, Masaki Imai, Michiko Koga, Shinya Yamamoto, Eisuke Adachi, Makoto Saito, Takeya Tsutsumi, Amato Otani, Yukie Kashima, Tetsuhiro Kikuchi, Hiroshi Yotsuyanagi, Yutaka Suzuki, Yoshihiro Kawaoka

2023The Lancet Infectious Diseases21 citationsDOIOpen Access PDF

Topics & Concepts

Bivalent (engine)VirologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)BiologyMedicineChemistryInfectious disease (medical specialty)PathologyMetalDiseaseOrganic chemistrySARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections StudiesViral gastroenteritis research and epidemiology
Efficacy of antivirals and bivalent mRNA vaccines against SARS-CoV-2 isolate CH.1.1 | Litcius